AU Stock MarketDetailed Quotes
NOXOA Noxopharm Ltd
- 0.001
- 0.0000.00%
20min DelayTrading Aug 9 16:00 AET
292.24KMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.001Pre Close0.00Turnover0.00152wk High0.00%Turnover Ratio292.24MShares0.00152wk Low--EPS TTM190.86KFloat Cap0.320Historical High0.00P/E (Static)190.86MShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Noxopharm Ltd Company
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.
Company Profile
SymbolNOXOA
Company NameNoxopharm Ltd
Founded2015
MarketASX
Fiscal Year Ends06-30
Address821 Pacific Highway Level 20, Tower A The Zenith
CitySydney
CountryAustralia
Zip Code2067
Phone+61 291442223
Websitehttps://www.noxopharm.com
Share Registry--
Company Executives
- Name
- Position
- Salary
- Graham E Kelly
- Executive Director,Chief Executive Officer,Managing Director
- --
- Peter Ashley Marks
- Non-Executive Director,Non-Executive Deputy Chairman
- --
- Frederick (Fred) Bart
- Non-Executive Director,Non-Executive Chairman
- --
- Boris Patkin
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg